$ATNM News Article - Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial of Iomab-B in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia https://marketwirenews.com/news-releases/acti...05286.html
(0)
(0)
Actinium Pharmaceuticals, Inc. (ATNM) Stock Research Links